Objective: To compare the results of cervical cytology and high-risk HPV tests using samples obtained using two different collection modalities in a population of Brazilian women: self-collection (vaginal lavage) and cervical Pap testing. Methods: We enrolled 204 women who were aged 18-64 years and had previously obtained abnormal cervical cytology test results; 83.8% of them agreed to participate. The sample was divided into two aliquots: one for the cytological study and one for the molecular analysis of high-risk HPV. Results: Fifty-eight percent of the participants preferred to utilize self-collection as an alternative screening method. However, we noticed that the HPV positivity rate was significantly lower in self-collected samples when compared to those obtained using the conventional collection method (p = 0.035). The cytology tests of the samples obtained via self-collection were sensitive and had a positive predictive value and an area under the curve (AUC) that were significantly lower than those of the Pap test. However, the specificity and negative predictive value of these tests were similar. When compared with the HPV test, the self-collected samples demonstrated lower accuracy in predicting high-grade cervical intraepithelial neoplasia or worse, with a significantly lower sensitivity, positive predictive value, and AUC than the cervical Pap test samples. Conclusion: Self-collection by vaginal lavage is simple and well accepted by women. Due to its limitations, however, self-collection by lavage should be utilized with caution.

Journal Section:
Editor's choice
Keywords:
Self-collection, Molecular diagnostic techniques, Cervical neoplasms, Papillomavirus infections, Secondary prevention
1.
World Health Organization: Initiative for Vaccine Research (IVR) - Viral Cancer - HPV. Geneva, World Health Organization, 2011/2012.
2.
Ribeiro KC: Epidemiologia do câncer do colo do útero - Fatores demográficos e fatores de risco. São Paulo, Tecmedd, 2007.
3.
Ronco G, Giorgi Rossi P: New paradigms in cervical cancer prevention: opportunities and risks. BMC Womens Health 2008;8:23.
4.
Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, Rozendaal L, Jaspars LH, Voorhorst FJ, Verheijen RH, Meijer CJ: Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. J Clin Pathol 2002;55:435-439.
5.
Ministério da Saúde: Diretrizes brasileiras para o rastreamento do câncer do colo do útero/Instituto Nacional de Câncer. Coordenação Geral de Ações Estratégicas. Divisão de Apoio à Rede de Atenção Oncológica. Rio de Janeiro, Instituto Nacional de Câncer, 2011, vol 1, p 104.
6.
IBGE: Pesquisa Nacional por Amostra de Domicilio. Um panorama da saúde no Brasil: acesso e utilização de serviços, condições de saúde e fatores de risco e proteção à saúde 2008. Rio de Janeiro, IBGE, 2010.
7.
Costa RF, Longatto-Filho A, Pinheiro C, Zeferino LC, Fregnani JH: Historical analysis of the Brazilian Cervical Cancer Screening Program from 2006 to 2013: a time for reflection. PLoS One 2015;10:e0138945.
8.
Montealegre JR, Landgren RM, Anderson ML, Hoxhaj S, Williams S, Robinson DJ, Scheurer ME, Ramondetta LM: Acceptability of self-sample human papillomavirus testing among medically underserved women visiting the emergency department. Gynecol Oncol 2015;138:317-322.
9.
Snijders PJ, Verhoef VM, Arbyn M, Ogilvie G, Minozzi S, Banzi R, van Kemenade FJ, Heideman DA, Meijer CJ: High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int J Cancer 2013;132:2223-2236.
10.
Crofts V, Flahault E, Tebeu PM, Untiet S, Fosso GK, Boulvain M, Vassilakos P, Petignat P: Education efforts may contribute to wider acceptance of human papillomavirus self-sampling. Int J Womens Health 2015;7:149-154.
11.
Scarinci IC, Litton AG, Garcés-Palacio IC, Partridge EE, Castle PE: Acceptability and usability of self-collected sampling for HPV testing among African-American women living in the Mississippi Delta. Womens Health Issues 2013;23:e123-e130.
12.
Guan Y, Castle PE, Wang S, Li B, Feng C, Ci P, Li X, Gravitt P, Qiao YL: A cross-sectional study on the acceptability of self-collection for HPV testing among women in rural China. Sex Transm Infect 2012;88:490-494.
13.
Racey CS, Gesink DC: Barriers and facilitators to cervical cancer screening among women in rural Ontario, Canada: the role of self-collected HPV testing. J Rural Health 2016;32:136-145.
14.
Virtanen A, Nieminen P, Niironen M, Luostarinen T, Anttila A: Self-sampling experiences among non-attendees to cervical screening. Gynecol Oncol 2014;135:487-494.
15.
Jentschke M, Chen K, Arbyn M, Hertel B, Noskowicz M, Soergel P, Hillemanns P: WITHDRAWN: Comparative evaluation of two vaginal self-sampling devices for the detection of human papillomavirus infections. J Clin Virol DOI: 10.1016/j.jcv.2015.08.011.
16.
Longatto-Filho A, Roteli-Martins C, Hammes L, Etlinger D, Pereira SM, Erzen M, Branca M, Naud P, Derchain SF, Sarian LO, Matos J, Gontijo R, Lima T, Maeda MY, Tatti S, Syrjänen S, Syrjänen K: Self-sampling for human papillomavirus (HPV) testing as cervical cancer screening option. Experience from the LAMS study. Eur J Gynaecol Oncol 2008;29:327-332.
17.
Holanda F Jr, Castelo A, Veras TM, de Almeida FM, Lins MZ, Dores GB: Primary screening for cervical cancer through self sampling. Int J Gynaecol Obstet 2006;95:179-184.
18.
Syrjänen K, Naud P, Derchain S, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Hammes LS, Matos J, Gontijo R, Sarian L, Braganca J, Arlindo FC, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S: Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study. Anticancer Res 2005;25:3469-3480.
19.
Lorenzi AT, Fregnani JH, Possati-Resende JC, Neto CS, Villa LL, Longatto-Filho A: Self-collection for high-risk HPV detection in Brazilian women using the careHPV™ test. Gynecol Oncol 2013;131:131-134.
20.
Jones HE, Wiegerinck MA, Nieboer TE, Mol BW, Westhoff CL: Women in the Netherlands prefer self-sampling with a novel lavaging device to clinician collection of specimens for cervical cancer screening. Sex Transm Dis 2008;35:916-917.
21.
Wang SM, Hu SY, Chen F, Chen W, Zhao FH, Zhang YQ, Ma XM, Qiao YL: Clinical evaluation of human papillomavirus detection by careHPV™ test on physician-samples and self-samples using the indicating FTA Elute® card. Asian Pac J Cancer Prev 2014;15:7085-7089.
22.
Labani S, Asthana S: Human papillomavirus viral load on careHPV testing of self-collected vaginal samples vs clinician-collected cervical samples. Eur J Obstet Gynecol Reprod Biol 2014;181:233-239.
23.
Valdez M, Jeronimo J, Bansil P, Qiao YL, Zhao FH, Chen W, Zhang X, Kang LN, Paul P, Bai P, Peck R, Li J, Chen F, Stoler MH, Castle PE: Effectiveness of novel, lower cost molecular human papillomavirus-based tests for cervical cancer screening in rural China. Int J Cancer 2016;138:1453-1461.
© 2017 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2017
You do not currently have access to this content.